FDA Clearance Tracker · K191961
OrthoGold
Last checked: Nov 20, 2026Latest source record: Nov 26, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Nov 26, 2019
Substantially Equivalent
Time to decision
126 days
Received Jul 23, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K191961
- Device name
- OrthoGold
- Applicant
- Tissue Regeneration Technologies
- Applicant location
- Woodstock, GA
- Received
- Jul 23, 2019
- Decided
- Nov 26, 2019
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 878.4685
- Specialty
- General & Plastic Surgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code PZL. The earliest in FDA's data is DEN160037, decided Dec 28, 2017.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K191961
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Tissue Regeneration Technologies
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- OW100S (model OW100S-US)510(k)
K213120 · Decided Oct 12, 2022 · 380 days after receipt
Device type: Massager, Therapeutic, Electric (ISA) · Physical Medicine & Rehabilitation
- OrthoGold 100510(k)
K210451 · Decided May 5, 2021 · 78 days after receipt
Device type: Massager, Therapeutic, Electric (ISA) · Physical Medicine & Rehabilitation
- OrthoGold 100510(k)
K200926 · Decided Aug 28, 2020 · 143 days after receipt
Device type: Extracorporeal Shock Wave Device For Treatment Of Diabetic Foot Ulcers (PZL) · General & Plastic Surgery
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.